PCRX
Companies
NASDAQ
Pacira BioSciences Inc.
Health Care
$24.75
+$5.77 (+30.63%)
Price Chart
Overview
About PCRX
Pacira BioSciences Inc is a provider of non-opioid pain management and regenerative health solutions dedicated to advancing and improving outcomes for healthcare practitioners and their patients. The company has three commercialized non-opioid treatments: EXPAREL a long-acting, local analgesic currently approved for postsurgical pain management; ZILRETTA, an extended-release, intra-articular, corticosteroid injection indicated for the management of osteoarthritis; iovera, a novel, handheld device for delivering immediate, long-acting, drug-free pain control using precise, controlled doses of cold temperature to a targeted nerve.
Market Cap
$1.3B
Volume
25.6M
Avg. Volume
24.9M
P/E Ratio
8.669968
Dividend Yield
0.00%
Employees
745.0
Company Information
Exchange
NASDAQ
Sector
Health Care
Industry
Drug Manufacturers - Specialty & Generic
Website
Risk & Correlation Analysis
Market Correlation
1.55
High Correlation
Volatility
High (0.60)
Relative to market
Macro Factor Sensitivities
Interest Rates
Low Sensitivity
Inflation
Low Sensitivity
GDP Growth
Medium Sensitivity
Liquidity
Low Sensitivity
Commodity Prices
Low Sensitivity
Credit Quality
Medium Sensitivity
Portfolio Impact
Forecasts & Predictions
1-Month Target
$XXX.XX
+X.X% Potential
3-Month Target
$XXX.XX
+X.X% Potential
12-Month Target
$XXX.XX
+X.X% Potential
Technical Analysis
Based on technical indicators and chart patterns, PCRX shows...
AI Sentiment Analysis
Market sentiment analysis indicates...
Key Statistics
Market Cap$1.3B
Volume25.6M
P/E Ratio8.67
Dividend Yield0.00%
Important Dates
Next Dividend
Next Earnings
February 28, 2025Related Securities
Pricing info last updated June 19, 2025 (after market close)Other info last updated April 2, 2025